A Chiricozzi1,2, M Suárez-Fariñas3, J Fuentes-Duculan1, I Cueto1, K Li4, S Tian5, C Brodmerkel4, J G Krueger1. 1. Laboratory of Investigative Dermatology, The Rockefeller University, New York City, NY, U.S.A. 2. Department of Dermatology, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy. 3. Center for Clinical and Translational Science, The Rockefeller University, New York City, NY, U.S.A. 4. Immunology Systems Pharmacology & Biomarkers, Janssen Research & Development, Radnor, PA, U.S.A. 5. Division of Clinical Epidemiology, First Hospital of Jilin University, Changchun, Jilin, China.
Abstract
BACKGROUND: Psoriasis vulgaris is an inflammatory immune-mediated disease, with lesional skin characterized by sharply demarcated, erythematous scaly plaques. Uninvolved psoriatic skin appears clinically similar to normal skin. However, it has been hypothesized that inflammatory cytokines, e.g. interleukin (IL)-17, may affect any organ or tissue having a vascular supply; thus, distant uninvolved skin could be exposed to increased circulating IL-17. OBJECTIVES: To establish comparative genomic profiles between noninvolved skin and normal skin, in particular, determining immune abnormalities in distant uninvolved skin. METHODS: We performed a meta-analysis on three gene array studies, comparing the nonlesional (NL) psoriatic skin transcriptome with normal gene expression. We investigated immunological features of noninvolved skin, particularly linked to IL-17 signalling. RESULTS: We detected 252 differentially expressed gene transcripts in uninvolved skin compared with normal skin; multiple immune-related genes, including IL-17-downstream genes, were upregulated. Increased expression of IL-17-signature genes (e.g. DEFB4 and S100A7) was associated with an increased number of CD3+, CD8+ and DC-LAMP+ cells in NL skin vs. normal controls. Inducible T-cell costimulator (ICOS) expression was detected only in a few T-cells within NL skin. CONCLUSIONS: Our data described the genomic profile in NL skin, characterizing the immune activation that was mainly attributed to IL-17 signalling.
BACKGROUND:Psoriasis vulgaris is an inflammatory immune-mediated disease, with lesional skin characterized by sharply demarcated, erythematous scaly plaques. Uninvolved psoriatic skin appears clinically similar to normal skin. However, it has been hypothesized that inflammatory cytokines, e.g. interleukin (IL)-17, may affect any organ or tissue having a vascular supply; thus, distant uninvolved skin could be exposed to increased circulating IL-17. OBJECTIVES: To establish comparative genomic profiles between noninvolved skin and normal skin, in particular, determining immune abnormalities in distant uninvolved skin. METHODS: We performed a meta-analysis on three gene array studies, comparing the nonlesional (NL) psoriatic skin transcriptome with normal gene expression. We investigated immunological features of noninvolved skin, particularly linked to IL-17 signalling. RESULTS: We detected 252 differentially expressed gene transcripts in uninvolved skin compared with normal skin; multiple immune-related genes, including IL-17-downstream genes, were upregulated. Increased expression of IL-17-signature genes (e.g. DEFB4 and S100A7) was associated with an increased number of CD3+, CD8+ and DC-LAMP+ cells in NL skin vs. normal controls. Inducible T-cell costimulator (ICOS) expression was detected only in a few T-cells within NL skin. CONCLUSIONS: Our data described the genomic profile in NL skin, characterizing the immune activation that was mainly attributed to IL-17 signalling.
Authors: Michelle A Lowes; Francesca Chamian; Maria Veronica Abello; Judilyn Fuentes-Duculan; Shao-Lee Lin; Rachel Nussbaum; Inna Novitskaya; Henrietta Carbonaro; Irma Cardinale; Toyoko Kikuchi; Patricia Gilleaudeau; Mary Sullivan-Whalen; Knut M Wittkowski; Kim Papp; Marvin Garovoy; Wolfgang Dummer; Ralph M Steinman; James G Krueger Journal: Proc Natl Acad Sci U S A Date: 2005-12-27 Impact factor: 11.205
Authors: Michelle A Lowes; Toyoko Kikuchi; Judilyn Fuentes-Duculan; Irma Cardinale; Lisa C Zaba; Asifa S Haider; Edward P Bowman; James G Krueger Journal: J Invest Dermatol Date: 2008-01-17 Impact factor: 8.551
Authors: Lisa C Zaba; Judilyn Fuentes-Duculan; Ralph M Steinman; James G Krueger; Michelle A Lowes Journal: J Clin Invest Date: 2007-09 Impact factor: 14.808
Authors: Vivaswath S Ayyar; Jong Bong Lee; Weirong Wang; Meghan Pryor; Yanli Zhuang; Thomas Wilde; An Vermeulen Journal: Front Pharmacol Date: 2022-04-25 Impact factor: 5.988
Authors: Kaiyuan Wu; Allen Seylani; Jing Wu; Xufeng Wu; Christopher K E Bleck; Michael N Sack Journal: Autophagy Date: 2021-03-11 Impact factor: 16.016
Authors: Kristina Navrazhina; Sandra Garcet; John W Frew; Xiuzhong Zheng; Israel Coats; Emma Guttman-Yassky; James G Krueger Journal: J Am Acad Dermatol Date: 2021-07-30 Impact factor: 11.527